Wells Fargo cuts Ultragenyx Pharma PT to $18 from $50
Wells Fargo lowered its price target on Ultragenyx Pharma to $18.00 per share from $50.00, according to ratings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.